Cetera Investment Advisers’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Buy |
358,952
+2,671
| +0.7% | +$17K | ﹤0.01% | 1743 |
|
|
2025
Q1 | $1.73M | Buy |
356,281
+79,034
| +29% | +$384K | ﹤0.01% | 1847 |
|
|
2024
Q4 | $2.65M | Sell |
277,247
-107,236
| -28% | -$1.03M | 0.01% | 1445 |
|
|
2024
Q3 | $3.21M | Buy |
384,483
+257,852
| +204% | +$2.15M | 0.01% | 1277 |
|
|
2024
Q2 | $864K | Sell |
126,631
-44,320
| -26% | -$302K | ﹤0.01% | 2184 |
|
|
2024
Q1 | $433K | Buy |
+170,951
| New | +$433K | ﹤0.01% | 2719 |
|